Michael D. Kappelman, MD, MPH

University of North Carolina at Chapel Hill School of Medicine

Poster(s):

• (050) Compared to Thiopurines and Tumor Necrosis Factor Inhibitors Novel Biologics Are Associated with Reduced Risk of Non-Melanoma Skin Cancer Among Patients with Inflammatory Bowel Disease
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST